TRPM4 and glioma: High expression of TRPM4 predicted worse overall survival in lower-grade glioma (LGG), uveal melanoma (UVM), kidney renal clear cell carcinoma (KIRC), pancreatic adenocarcinoma (PAAD), mesothelioma (MESO), and thyroid carcinoma (THCA).